Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA approves Mifeprex for termination of early pregnancy

Oct. 2, 2000

SBIR grant awarded to Imgenex to develop monoclonal antibodies for osteoporosis

Oct. 2, 2000

Novel vitronectin receptor antagonists and their use in bone disorders patented

Sep. 29, 2000

Novasite awarded Phase I SBIR grant for lead molecule identification

Sep. 29, 2000

Novel cathepsin K inhibitors reportedly useful for osteoporosis

Sep. 28, 2000

Tissue-selective estrogens patented by Schering

Sep. 28, 2000

NDA submitted for combined niacin/lovastatin cholesterol product

Sep. 28, 2000

Thyroid receptor ligands particularly useful in the treatment of obesity

Sep. 27, 2000

European patent issued to Pfizer covers new NPY antagonists

Sep. 27, 2000

Benzimidazole FBPase inhibitors and their use in diabetes and related disorders

Sep. 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...